Genpact LtdG
Price$34.70Intrinsic value$61.6978% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5.3B+10.1% YoYTTM through 30 Jun 2026
Net Income $582.7M+13.4% YoYTTM through 30 Jun 2026
Free Cash Flow $572.1MTTM through 30 Jun 2026

Margins

Current
Gross Margin36.0%
EBITDA Margin16.5%
Operating Margin14.8%
Net Margin11.1%

Returns

22.1%ROE
9.5%ROA
17.8%ROIC

Balance Sheet Health

Debt / Equity0.61x
Current Ratio1.66x
Net Debt$332.5M
Cash & Equivalents$517.4M

Quality Metrics

Altman Z-Score3.29
Piotroski F-Score8 / 9
FCF Margin10.9%
Rule of 4014.4

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $5.1B
Diluted EPS$3.36TTM
'19'20'21'22'23'24'25
FY2025: $3.13

Dividend

$0.38Per share, FY20262.30%Yield-2.7%5-yr growth

Capital Allocation

Capex Intensity1.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.